Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 164, Issue 2, Pages 213-223
Publisher
Wiley
Online
2010-12-30
DOI
10.1111/j.1476-5381.2010.01196.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Betulinic acid, a natural compound with potent anticancer effects
- (2010) Franziska B. Mullauer et al. ANTI-CANCER DRUGS
- Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice
- (2010) N. Xia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Resveratrol: A Multifunctional Compound Improving Endothelial Function
- (2009) Huige Li et al. CARDIOVASCULAR DRUGS AND THERAPY
- Prevention of Atherosclerosis by Interference with the Vascular Nitric Oxide System
- (2009) Huige Li et al. CURRENT PHARMACEUTICAL DESIGN
- Resveratrol bioavailability and toxicity in humans
- (2009) Charles-Henry Cottart et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Pentacyclic Triterpene Distribution in Various Plants – Rich Sources for a New Group of Multi-Potent Plant Extracts
- (2009) Sebastian Jäger et al. MOLECULES
- Molecular mechanisms underlying the activation of eNOS
- (2009) Ingrid Fleming PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase Enhancer AVE9488 After Experimental Myocardial Infarction
- (2008) Daniela Fraccarollo et al. CIRCULATION
- Resveratrol stimulates nitric oxide production by increasing estrogen receptor α-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells
- (2008) Carolyn M. Klinge et al. FASEB JOURNAL
- Renin Inhibitor Aliskiren Improves Impaired Nitric Oxide Bioavailability and Protects Against Atherosclerotic Changes
- (2008) Toshio Imanishi et al. HYPERTENSION
- Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression
- (2008) Jürg Nussberger et al. HYPERTENSION
- Addition of Eplerenone to an Angiotensin-Converting Enzyme Inhibitor Effectively Improves Nitric Oxide Bioavailability
- (2008) Toshio Imanishi et al. HYPERTENSION
- More NO-No More ROS
- (2008) Johann Bauersachs et al. HYPERTENSION
- Aliskiren Improves Nitric Oxide Bioavailability and Limits Atherosclerosis
- (2008) Subodh Verma et al. HYPERTENSION
- Antiatherosclerotic Effects of Small-Molecular-Weight Compounds Enhancing Endothelial Nitric-Oxide Synthase (eNOS) Expression and Preventing eNOS Uncoupling
- (2008) P. Wohlfart et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy
- (2008) M. Satoh et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies
- (2008) Ulrich Förstermann Nature clinical practice. Cardiovascular medicine
- Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus
- (2007) Philip Wenzel et al. ATHEROSCLEROSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started